Cookie preferences

Essential storage keeps iPulse AI reliable. Optional analytics and LinkedIn ad measurement stay off unless you accept. Privacy Policy

Skip to main content
Aehr Test Systems logo
AEHR.NASDAQ
Aehr Test Systems
Information Technology · Semiconductor Materials & Equipment

Semiconductor test equipment company supplying wafer-level burn-in and test systems for silicon carbide, sensors, and photonics.

HQ: United StatesListed: United States

AEHR: Aehr Test Systems Stock Price, Analysis & Forecast: 1 Year and 5 Year Targets

Updated Deep analysis published 12 min read
Approved byRusslan Ramdowar, Editor-in-Chief

Aehr Test Systems: 1-Year and 5-Year Forecast Outlook and Rating

Aehr Test Systems (AEHR) has an immediate No Action - Keep Monitoring consensus AI recommendation, based on 11 AI analysts.

  • The 1-year target is $47.5 for , with +19.23% expected return (+19.23% including net dividends) and a STRONG BUY rating.

  • The 5-year target is $55.0 for , with +38.05% expected return (+38.05% including net dividends) and a NEUTRAL rating.

Returns and dividends calculation details

Latest available market price: USD 39.8, as of 20 Nov 2026.

Calculated net annual dividend yield: 0%. As of 2026-11-20.

Gross TTM: 0% · Two-year annualized gross: 0%.

Tax withholding assumption: 30% (US). One-off special payments are excluded.

Original published assumption: 0% per year.

Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.

Targets retain their original publication dates. Returns use the dated market close and the time remaining to each fixed target date. Current ratings also require fresh quotes and analysis, with more than 90 days remaining. Past targets have no forward return. Eligibility checked .

Aehr Test Systems Flagship Insight

The AI Testing Ramp Must Clear Its Toughest Test: Cash

A technician beside an Aehr semiconductor testing machine.

High consensus supports expanding AI burn-in demand, proprietary interface sales and operating leverage, but substantial business growth may not translate into shareholder value. Concentrated procurement, weak cash conversion, dilution and valuation normalization challenge claims of an infrastructure monopoly; production qualification remains the decisive upside gate.

How were the Investment Thesis and Forecasts created?

11 AI advisors, guided by 9 analytical frameworks, contribute to the deep analysis by iPulse AI Engine.

  • Ray Dalio (Strategist)
  • Warren Buffett (Value Purist)
  • Michael Burry (Vulture)
  • Superintelligence (Anthropologist)
  • Sherlock Holmes (Whistleblower)
  • Elon Musk (Visionary)
  • Machiavelli (Insider)
  • Universal Investor (Polymath)
  • J.P. Morgan (Titan)

Ran across these frontier AI models

  • Google Gemini 4 Hydrogen
  • OpenAI GPT-6.1 Sol
  • Anthropic Claude Opus 5.5

Aehr Test Systems: Investment Thesis Summary

If you invest $10,000 in Aehr Test Systems at the latest market close (20 Nov 2026): $13,805 by Nov 2031 versus $14,502 for S&P 500 benchmark.

Returns use the same dated market close, fixed targets and remaining dividend period as the forecast table.

Five-year synthesized consensus forecast for Aehr Test SystemsThe diagram shows the synthesized consensus value path for Aehr Test Systems, forecast milestones, and a comparison with S&P 500 benchmark. excluding any dividend yield adjustment.$10,000$12,000$14,000$16,000$13,805 (+38.05%)$14,502 (+45.02%)Latest close2026-11-202027(1Y)2028(2Y)2029(3Y)2030(4Y)2031Fixed target
Aehr Test Systems · ConsensusS&P 500 benchmark
Figure: Five-year synthesized consensus value path for Aehr Test Systems compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.

Aehr Test Systems is expanding a commercially validated AI reliability franchise, but equity value depends on cash captured per share rather than semiconductor spending. Repeat Sonoma and FOX orders, proprietary interfaces and improving manufacturing absorption support substantial business growth. Against that, a starting valuation near thirteen times guided fiscal 2027 sales embeds execution before cash conversion is established. Customer concentration, normal tax expense and dilution can offset operating leverage through multiple normalization. The strongest counterargument is that successive processor generations and another production customer extend the ramp long enough to earn the premium; current evaluations are not purchase commitments.

Key insights

  • Installed tools create design-linked aftermarket revenue, yet interfaces remain exposed to customer utilization; recurring purchases therefore deserve less duration than contractual subscription cash flows.
  • Low fixed-asset spending shifts investment risk into inventory, receivables and engineering, making cash conversion more informative than headline capital expenditure for valuation.
  • Faster screening can improve customer economics while reducing tool requirements, so expanding AI output and supplier revenue intensity need not move together.

Continue reading Aehr Test Systems analysis with Base subscription

See Base access
Protected research workspace

Aehr Test Systems: 5 Year Consensus Forecast

20 quarterly price targets, returns and rationale, with advisor range and benchmark

Forward returns are updated using the latest market close price of USD 39.8, as of 20 Nov 2026.

Dividend calculation details

Calculated net annual dividend yield: 0%. As of 2026-11-20.

Gross TTM: 0% · Two-year annualized gross: 0%.

Tax withholding assumption: 30% (US). One-off special payments are excluded.

Original published assumption: 0% per year.

Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.

The consensus target follows an expert-weighted price path synthesized from 11 AI advisor opinions. See Opinion weights and rationale for the exact allocation and reasoning.

Forecast methodology and reference values

Published targets are anchored on 13 Nov 2026 at USD 57. Original quarter-to-quarter target changes are retained. Forward returns use the remaining time to each fixed target date.

The pessimistic and optimistic advisor base cases are the lowest and highest published advisor base-case targets for each quarter. The advisor at either extreme can change between quarters. Benchmark values are in USD.

Scroll the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in USD, with price returns, cumulative returns including net dividends and rationale; separate individual advisor range, benchmark and applicable FX forecasts
QuarterConsensus target (USD)Forecast quarter-to-quarter price changeForward price returnForward return incl. net dividendsForecast rationalePessimistic Advisor Base Case (USD)Optimistic Advisor Base Case (USD)S&P 500 benchmark (USD)
$52.8-7.30%+32.53%+32.53%Strong production shipments are outweighed by scrutiny of collections and the demanding entry multiple. The qualified next processor supports demand, but the favored scenario reduces valuation before investors grant credit for a broader, cash-generative franchise.$46.9$60.3$736
$52.3-0.98%+31.28%+31.28%Second-processor orders and evaluation progress provide a counterweight to continued working-capital demands. The balance remains slightly adverse: shipment visibility improves, but collections and qualification timing prevent a decisive earnings-driven rerating in this modeled period.$39.9$65.1$724
$52.5+0.35%+31.78%+31.78%Fiscal-year execution broadly validates the production ramp, producing limited recovery rather than renewed enthusiasm. Better absorption competes with tougher forward comparisons, normalized taxes and uncertainty over whether prospective customers become material production buyers in this scenario.$42.7$67.0$722
$47.5-9.42%+19.23%+19.23%Attention shifts from backlog fulfillment to replacement bookings and the next growth phase. Most weighted paths assume slower order momentum or acceptance timing, exposing concentration and extending valuation normalization despite a substantially stronger operating business.$37.6$61.9$724
$48.0+0.99%+20.48%+20.48%Repeat processor activity and interface demand support a modest recovery from the reset. Some paths instead anticipate capacity digestion, so earnings visibility improves only cautiously and does not justify restoring the original scarcity premium.$37.5$64.8$735
$47.9-0.31%+20.23%+20.23%Improving collections and contactor purchases meet a competing assumption of fewer incremental system orders. These forces largely offset, leaving mild pressure as investors distinguish better cash realization from evidence of a sustained new capacity cycle.$35.6$58.5$752
$46.3-3.38%+16.21%+16.21%Annual planning exposes uneven equipment additions and possible utilization softness. Interface demand cushions the business, but the weighted scenario gives greater influence to lower book-to-bill and restrained forward growth than to immediate diversification benefits.$32.4$55.9$754
$46.4+0.41%+16.47%+16.47%Incremental photonics deployments and selective capacity additions support stabilization. Some paths retain a deeper processor-generation pause, limiting the recovery; the scenario rewards a broader earnings base without assuming fleetwide optical adoption or another transformational award.$33.6$58.7$780
$48.2+3.73%+20.98%+20.98%Processor variants and the larger installed base generate additional interface demand, improving product mix and expense absorption. Lingering digestion in more cautious paths tempers confidence, but earnings resilience becomes more influential than the earlier valuation reset.$35.9$61.6$802
$48.4+0.45%+21.49%+21.49%Replacement interfaces, refresh bookings and steadier collections provide slight support. The important counterweight is customer productivity: higher throughput can defer tool purchases, so improved semiconductor output does not automatically establish accelerating equipment demand this period.$34.5$65.3$819
$48.1-0.57%+20.73%+20.73%Competitive quotations and application-development spending restrain the earnings recovery. Some paths show stronger diversification and cash generation, but the balance remains mildly adverse as investors recognize the recurring investment needed to defend qualified production positions.$35.1$63.3$821
$49.6+3.03%+24.50%+24.50%Steadier collections and repeat interface sales help cash generation substantiate accounting earnings. Optical contributions and selected qualification completions support recovery, while customer acceptance volatility prevents the market from treating the franchise as a contractual annuity.$33.4$65.8$842
$51.5+3.82%+29.27%+29.27%Successive processor designs and higher thermal requirements support upgrades and design-linked consumables. A broader installed base spreads engineering costs, allowing earnings-led appreciation even though some customers continue digesting earlier equipment purchases within the modeled cycle.$31.4$68.5$863
$51.1-0.80%+28.26%+28.26%Procurement negotiations, component costs and more efficient screening limit incremental margins. Better cash control and interface attachment cushion operations, but the weighted scenario modestly reduces valuation rather than extrapolating another uninterrupted phase of operating leverage.$32.3$65.2$871
$50.7-0.77%+27.26%+27.26%Maturing growth and screening productivity constrain the valuation investors assign to profitable expansion. Photonics and power-device orders offer offsets, yet equipment-replacement lulls and competitive economics slightly outweigh the improving scale of the business this period.$31.1$67.0$874
$52.4+3.37%+31.53%+31.53%Working-capital requirements stabilize relative to revenue, while interface redesigns renew repeat demand. Greater cash backing for earnings supports recovery, with the company increasingly valued as a profitable equipment specialist rather than an unrestricted AI royalty.$30.1$69.7$896
$53.8+2.67%+35.04%+35.04%Replacement interfaces and selective platform upgrades sustain earnings growth across established AI and optical programs. Second-sourcing concerns persist in opposing paths, but broader utilization and reusable engineering capabilities provide more support than dilution removes in this scenario.$30.7$67.7$912
$54.1+0.66%+35.79%+35.79%Stable cash realization and a broader application mix provide modest support despite pauses between customer capacity phases. Normal taxes, procurement discipline and dilution limit the extent to which larger enterprise profits translate into per-share progress.$29.8$70.3$924
$53.7-0.77%+34.79%+34.79%Operating results support a substantially larger business, but terminal-growth expectations cool as equipment demand matures. Competitive pricing and product-transition costs slightly outweigh improving collections, keeping the valuation anchored to normalized earnings rather than thematic exposure.$30.4$71.7$939
$55.0+2.47%+38.05%+38.05%Repeat interface demand and disciplined costs support the forward earnings base. The scenario ends with improving cash generation but a normalized equipment multiple, leaving the original valuation premium and dilution as continuing constraints on shareholder participation.$29.8$72.5$965
Show remaining 18 quartersCollapse to first 2 quarters

All 20 quarters are displayed in the table above.

Aehr Test Systems Stock Analysis & Scenarios Deep Dive

IMPORTANTChange magnitude

Aehr Test Systems: Did the investment thesis change since the last deep analysis in September 2026?

The operating-growth premise survives, but repeat processor orders and recovered margins materially weaken the prior thesis of an inevitable severe reset.

Changes in the underlying thesis, rather than the passage of time alone.

  • The previous view treated post-installation digestion and incumbent encroachment as effectively assured. Current production disclosures support continuing demand, while specific competitive displacement and the timing of digestion remain unproven.
  • The latest filing documents stronger profitability but continued operating cash consumption. Fiscal-period duplication also undermines trailing-multiple precision, shifting the investment case toward forward normalized earnings, collections and customer diversification rather than categorical downside.

Aehr Test Systems: Alpha Gap & Repricing Catalysts

Market Narrative

What does the market currently expect? November analyst-summary articles retain optimistic growth expectations even as target cuts and sharp post-results selling signal concentration anxiety. Price-based inference still suggests a demanding AI franchise premium, but it does not establish investor unanimity. Media depictions range from an essential reliability supplier to another cyclical, customer-dependent equipment ramp; reported positioning figures lack consistent verification.

Alpha Gap

What is the biggest difference between market expectations and our AI forecasts? The best-supported gap is overpricing, although its magnitude remains uncertain. The analytical distinction is between repeat production adoption and durable cash capture per share: concentrated customers retain control of capacity additions, while interfaces remain production-sensitive and growth consumes working capital. That limits the valuation warranted by genuine AI exposure. Successive processor generations and another substantial customer could nevertheless extend earnings growth enough to absorb normalization. External expectations are polarized, so this is not a demonstrated consensus-wide blind spot.

Repricing Catalyst

What could make the market recognize and close that gap? The next two cash-flow and bookings reports, expected in early-to-mid 2027, provide the clearest test because they reconcile shipment growth with collections and replacement orders. Persistent cash absorption alongside maintained guidance would support downward valuation normalization. Conversely, a material FOX-XP production award during 2027–2028 could invalidate that interpretation. Optical production commitments during 2028–2030 offer a later diversification catalyst, but evaluations alone cannot close the gap.

Aehr Test Systems: Sentiment and Timing

What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?

Greed and Fear Sentiment
Mixed
Volatility Regime
High Erratic
Convergence Cycle Position
Mixed

Volatility expectations converge, but sentiment splits between a residual AI valuation overshoot and an already advancing reversal. The decisive tension is whether recent selling has discounted concentration sufficiently, making a rebound possible before cash-flow evidence resolves the longer-term thesis.

Macro Regime Fit

Does the current market environment support the thesis? The setup is mixed, with an adverse valuation bias under the supplied elevated-yield assumptions. AI infrastructure investment supports customer test-capacity budgets, but higher discount rates penalize earnings still awaiting cash realization. Concentrated procurement transmits customer financing retrenchment directly into orders; Taiwan-linked installation and acceptance add company-specific exposure beyond general semiconductor cyclicality.

Advisor Disagreement

What do our AI Advisors disagree about most? The real debate is whether successive processor generations and repeat interfaces sustain growth long enough to absorb a lower valuation multiple, or whether concentrated buyers pause before cash generation matures. Assumed digestion dates differ materially and are not established facts. The optimistic case also requires customer diversification; the cautious case gives more weight to normalized taxes, dilution and screening productivity. Separately, overlapping fiscal-period rows explain conflicting trailing multiples rather than an economic disagreement. Collections, replacement bookings and disclosed production awards would resolve more than another shipment-driven revenue beat.

Aehr Test Systems: Critical Influencing Factors

Near-certain positive forcesTop Drivers & Tailwinds

Near-certain forces that support the investment thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.

Scroll to view all columns

Top Drivers & Tailwinds with asset-specific estimated impacts and thesis rationale
Driver / TailwindCategoryEst. stock-price impactEst. earnings impactWhy it matters
Reliability demand becomes production revenueSector And Industry+40%+100%Repeat AI production orders provide firmer support than broad infrastructure-spending forecasts. Higher package value and thermal loads strengthen the economics of screening, while the qualified next processor extends an existing customer relationship. These forces support sustained systems and interface demand, although neither universal burn-in adoption nor proportional participation in AI spending is assumed.
Installed tools seed repeat interfacesCompetitive Positioning+25%+50%Device-specific contactors and modules extend revenue beyond initial equipment shipments. Qualification continuity and new chip designs create switching friction and repeat gross profit as the installed base expands. This aftermarket should persist across production generations, but reusable interfaces remain tied to utilization and redesigns rather than contractually recurring subscription payments.
Higher throughput spreads fixed costsOperational Efficiency+15%+45%The reported gross-margin recovery demonstrates that shipment volume can restore manufacturing absorption. External component sourcing and expanded assembly capacity allow output to rise without matching customers' fabrication investment. Engineering and corporate expenses can grow more slowly than sales, supporting normalized earnings, although qualification support and temporary utilization declines prevent uninterrupted margin expansion.
Photonics broadens the revenue baseInnovation And Product+20%+35%Follow-on silicon-photonics production orders establish a commercial foothold outside processor screening and the former silicon-carbide concentration. Incremental optical-device deployment can generate FOX systems and contactor demand while spreading application-development costs. This supports broader earnings sources over five years without assuming an industry-wide co-packaged-optics testing mandate or an immediate power-semiconductor rebound.

Near-certain negative forcesTop Frictions & Headwinds

Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.

Scroll to view all columns

Top Frictions & Headwinds with asset-specific estimated impacts and thesis rationale
Friction / HeadwindCategoryEst. stock-price impactEst. earnings impactWhy it matters
Entry valuation spends future profitsMacroeconomic And Macrofinancial-50%-0.0%A valuation near thirteen times guided fiscal 2027 sales capitalizes substantial execution before dependable cash generation exists. As percentage growth moderates, equipment cyclicality and elevated discount-rate hurdles should constrain the multiple investors pay. The pressure primarily affects equity valuation rather than operating earnings; better results need not prevent normalization, although its magnitude remains disputed.
Few buyers control the cadenceCompetitive Positioning-25%-30%Two customers supplied nearly three quarters of the latest reported quarter's revenue. Their qualification schedules, procurement decisions and capacity utilization therefore dominate shipment timing and negotiating leverage. Continued concentration makes uneven bookings and earnings plausible across multiple generations, but does not establish that a severe cancellation or a particular year's digestion cycle is inevitable.
Growth absorbs shareholder cashCapital Allocation-15%-15%The profitable latest quarter still consumed operating cash because the ramp required receivables, inventory and advance commitments. These funding needs delay distributable cash, while compensation expense and possible inventory provisions constrain earnings. Equity compensation also dilutes per-share progress. Ample liquidity provides runway, but it does not make growth self-funding or establish that another issuance is necessary.
Better screening limits supplier captureCompetitive Positioning-15%-20%Customers purchase adequate reliability capacity, not a royalty on semiconductor output. Rival thermal-control platforms, shorter stress cycles and better throughput require continuing engineering investment and constrain price-performance economics. Such pressure should persist as the market grows, limiting terminal margins and tools required per device without assuming a proven competitive displacement or wholesale technological bypass.

Aehr Test Systems: What Could Break or Accelerate the Thesis

Event Risk Score: Very High 95/100Asset-level relative pressure from clustered consensus frictions and tail risks. This is not the probability or risk score of an individual force.

Plausible downside scenariosTail Risks

Tail yet plausible downside scenarios selected for their highest potential impact.

Scroll to view all columns

Tail risks with plausibility, asset-specific potential impact and scenario rationale
Tail scenarioChance of OccurringStock Price ImpactWhy plausible / what changes
Anchor processor ramp is curtailed35%-55%A leading customer cancels, materially delays or downsizes a processor deployment during 2027–2029. Concentrated revenue would transmit the decision rapidly into lost shipments, stranded application-specific inventory and underabsorbed engineering costs, creating an earnings-and-multiple shock. Existing production and repeat orders keep this a minority scenario, but liquidity would protect corporate survival more effectively than shareholder value.
Taiwan interruption freezes customer acceptance20%-60%A sustained Taiwan shipping interruption, blockade or binding trade restriction prevents exposed installations and customer acceptance during 2027–2031. Delayed collections, stranded inventory and suspended follow-on orders could coincide with a higher equity risk premium. Disclosed OSAT deployments establish the operating channel, but no supplied evidence establishes disruption timing, keeping the event outside the base case.

Plausible upside scenariosTail Opportunities

Tail yet plausible upside scenarios selected for their highest potential impact.

Scroll to view all columns

Tail opportunities with plausibility, asset-specific potential impact and scenario rationale
Tail scenarioChance of OccurringStock Price ImpactWhy plausible / what changes
Processor evaluation becomes production fleet45%+65%The major processor supplier's planned Taiwan FOX-XP evaluation converts into a material multi-system production award during 2027–2028. That would establish another substantial franchise, expanding systems and proprietary interface demand while reducing concentration. Probability remains below half because benchmarking success does not establish production economics, procurement approval or deployment breadth; an evaluation is not backlog.
Optical release triggers fleet orders30%+65%A commercial co-packaged optical-I/O release triggers multi-site FOX-XP production commitments during 2028–2030, exceeding the incremental photonics expansion in the base case. Existing production deployments provide a foothold, and simultaneous equipment and contactor orders could diversify earnings materially. Probability remains limited because architecture selection, manufacturing yields and the location of reliability screening are unresolved.

Company Financial AnalysisAehr Test Systems: Earnings and Financials Analysis by AI

Financial figures available as of Nov 16, 2026. Only filings and source records available by this analysis date are included. View latest Aehr Test Systems financials here.

Earnings and financials

Aehr's fiscal first-quarter 2027 issuer release, covering the period ended September 25, 2026, shows a genuine AI-led turnaround: revenue reached $33 million as production systems and interfaces shipped. This is stronger commercial evidence than an evaluation pipeline, and it reversed the earlier silicon-carbide downturn. The accompanying Form 10-Q nevertheless reports approximately $3.1 million of operating cash outflow. Inventory and receivables absorbed the ramp, so recognized profits have not yet become dependable cash generation. Duplicate quarterly feed entries and a separate fiscal-transition month make supplied trailing totals unreliable. The recovery is credible; whether it becomes a diversified, self-funding franchise remains unresolved.

Revenue, earnings, and cash flow

The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.

Revenue, net income, and free cash flow history
Fiscal yearRevenueNet incomeFree cash flow
2026USD 50MUSD -7.1MUSD -5.4M
2026USD 50MUSD -7.1MUSD -5.4M
2025USD 59MUSD -3.9MUSD -12.4M
2025USD 59MUSD -3.9MUSD -12.4M
2024USD 66.2MUSD 33.2MUSD 1M

Valuation context: historical P/E

The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.

Historical price-to-earnings ratios
Fiscal yearP/EEarnings basisCurrency basisTicker / reporting
2026--TTMLoss-makingUSD / USD
2026--TTMLoss-makingUSD / USD
2025--TTMLoss-makingUSD / USD
2025--AnnualLoss-makingUSD / USD
202410.0xAnnualNativeUSD / USD

P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.

Profitability and margins

Aehr's fiscal 2026 annual results and fiscal first-quarter 2027 issuer release show gross margin recovering from 35.3% to 47.5%. The Form 10-Q attributes improvement to higher volume, favorable product mix and better absorption of manufacturing overhead. More shipments are spreading existing costs across a larger revenue base. That is meaningful progress, but the same mechanism can reverse when major customers pause. Higher-margin interfaces help, while heavier system shipments can dilute the mix. Favorable tax effects and interest income also make current net profit different from normalized manufacturing earnings. The evidence supports recovery from the downturn, not proof of permanent pricing power or continuously expanding margins.

The table compares up to five fiscal years of operating income and reported profitability margins.

Operating income and margin history
Fiscal yearOperating incomeOperating marginNet margin
2026USD -14.1M-28.3%-14.3%
2026USD -14.1M-28.3%-14.3%
2025USD -4.3M-7.3%-6.6%
2025USD -4.3M-7.3%-6.6%
2024USD 10.1M15.2%50.1%

Balance sheet and leverage

The September 25, 2026 Form 10-Q reports $104.9 million of unrestricted cash and no funded borrowings on the balance sheet. This gives Aehr room to finance engineering and withstand delivery setbacks without a near-term debt refinancing problem. Operating leases and normal supplier obligations still require payment. The cushion was substantially financed through equity issuance rather than accumulated operating cash. Meanwhile, $53.1 million of inventory ties resources to customer programs that could change. Cash therefore protects execution more convincingly than it protects the stock's valuation. Employee share awards can also dilute owners, and tax-withholding share settlements should not be mistaken for a discretionary repurchase program.

The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.

Balance sheet leverage and liquidity history
Fiscal yearTotal debtCash + short-term investmentsReported net cash / (debt)Debt less (cash + short-term investments), calculatedCurrent ratio
2026USD 9.9MUSD 116.4MUSD 106.5M net cashUSD -106.5M10.33x
2026USD 9.9MUSD 116.4MUSD 106.5M net cashUSD -106.5M10.33x
2025USD 10.8MUSD 25.2MUSD 14.4M net cashUSD -14.4M5.68x
2025USD 10.8MUSD 25.2MUSD 14.4M net cashUSD -14.4M5.68x
2024USD 6.2MUSD 49.2MUSD 43M net cashUSD -43M9.31x

Reported net debt retains the source definition, which can deduct cash alone. Cash plus short-term investments is broader liquidity; the separately calculated column subtracts that full amount from total debt for the same fiscal period and currency. Reported net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.

Capex and investment intensity

Aehr's supplied fiscal 2026 annual figures show approximately $2.1 million of capital spending against $12.6 million of research and development. Management is investing mainly in engineering, qualification and production readiness rather than building a semiconductor fabrication plant. The annual report's externally sourced components and expanded assembly arrangements support flexible output growth. That flexibility reduces the risk of an oversized factory, but it does not make expansion cash-free. Components, demonstration equipment and customer-specific support must be funded before acceptance and collection. Returns depend on those commitments producing repeat orders. Customer AI-factory spending is therefore neither Aehr's own capital expenditure nor a guaranteed measure of its future revenue.

The table compares up to five fiscal years of capital expenditure and research-and-development investment.

Capital expenditure and research and development history
Fiscal yearCapital expenditureR&D spend
2026USD 2.1MUSD 12.6M
2026USD 2.1MUSD 12.6M
2025USD 5MUSD 10.5M
2025USD 5MUSD 10.5M
2024USD 749KUSD 8.7M

Behind the synthesisAehr Test Systems: How Each Individual AI Forecaster Opinion Shapes the Global Consensus

11 opinions · 100/100 allocated

This publication’s recorded synthesis allocated voting influence across 11 advisor opinions. The weights and rationales below are retained from that synthesis.

The strongest evidence is the combination of repeat production orders, the qualified next processor, reported margin recovery and operating cash outflow in the same quarter. These support a larger operating franchise without proving attractive per-share economics. Reports repeatedly reuse issuer releases and the same quarterly filing, so their agreement is not independent corroboration. Greater weight goes to analyses correcting overlapping fiscal periods, normalizing taxes and distinguishing shareholder distributions from employee withholding. A separate competitor disclosure strengthens the case that qualification does not guarantee monopoly pricing. The strongest contrary argument survives: successive processor generations could extend demand beyond the initial installation wave and support a tactical recovery. Lower allocations reflect unreconciled trailing metrics, deterministic digestion schedules, speculative political protection arguments and unsupported interpretations of insider selling. Adoption breadth, cash realization and the appropriate mature multiple remain unresolved.

Individual targets retain their original dates. Returns and ratings use the same latest available market close and dividend assumptions as the Consensus.

All 11 opinions
Superintelligence in an AI-generated research persona portrait

Superintelligence AI

Consensus weight Allocation: 18.0/100. Weight Allocation Rationale: This receives the largest allocation because it reconciles fiscal-period defects, separates normalized earnings from tax benefits and adds a distinct competitor disclosure beyond repeated issuer releases. Its operating-growth assumptions remain demanding, and competitive products do not prove lost qualifications. Nevertheless, the causal bridge from business expansion to constrained equity value is particularly coherent.

The 1-year target is $49.5 for , with +24.23% expected return and a STRONG BUY rating. The 5-year target is $60.9 for , with +52.96% expected return and a BUY rating.

Elon Musk in an AI-generated research persona portrait

Elon Musk AI

Consensus weight Allocation: 14.0/100. Weight Allocation Rationale: Primary filings and production-order disclosures support the distinction between genuine adoption and limited shareholder cash capture. Fiscal-period corrections and explicit dilution assumptions strengthen consistency. Serviceable-market estimates remain speculative, and the early valuation reset is scenario-dependent. Substantial overlap with other filing-based analyses limits incremental weight.

The 1-year target is $38.6 for , with -3.10% expected return and a SELL ALL rating. The 5-year target is $51.6 for , with +29.45% expected return and a NEUTRAL rating.

J.P. Morgan in an AI-generated research persona portrait

J.P. Morgan AI

Consensus weight Allocation: 14.0/100. Weight Allocation Rationale: Direct filings support its backlog-to-cash analysis, lease recognition and rejection of distorted trailing aggregates. It correctly distinguishes qualification advantages from control over customer budgets. The forward fiscal-year valuation basis is explicit and compatible with the forecast dates. Shared issuer evidence and assumed booking normalization prevent a larger allocation.

The 1-year target is $42.4 for , with +6.34% expected return and a NEUTRAL rating. The 5-year target is $45.0 for , with +12.98% expected return and a PARTIAL SELL rating.

Universal Investor in an AI-generated research persona portrait

Universal Investor AI

Consensus weight Allocation: 13.0/100. Weight Allocation Rationale: Primary disclosures support its fiscal-period reconciliation, working-capital diagnosis and separation of equipment demand from AI spending. The insight that faster screening can reduce required tools is economically important and survives scrutiny. Weight is restrained by correlated issuer sourcing and an assumed early repricing sequence that evidence cannot independently time.

The 1-year target is $37.5 for , with -5.92% expected return and a SELL ALL rating. The 5-year target is $47.4 for , with +18.88% expected return and a NEUTRAL rating.

Universal Investor in an AI-generated research persona portrait

Universal Investor AI

Consensus weight Allocation: 12.0/100. Weight Allocation Rationale: The qualified second processor provides a credible counterargument to an immediate order cliff, while externally attributed target cuts challenge claims of unanimous enthusiasm. Concentration and valuation remain acknowledged. Weight is moderated by uncertain trailing aggregates, assumed future issuance and unsupported connections between specific capital-market events and customer spending.

The 1-year target is $61.8 for , with +55.10% expected return and a STRONG BUY rating. The 5-year target is $72.5 for , with +81.87% expected return and a BUY rating.

Warren Buffett in an AI-generated research persona portrait

Warren Buffett AI

Consensus weight Allocation: 7.0/100. Weight Allocation Rationale: The focus on owner cash, consumables attachment and equity-funded liquidity is useful and consistent with supplied filings. Forward valuation offers a more defensible anchor than trailing metrics. Lower weight reflects incompletely traceable sources, unsupported historical cash-flow generalizations and assumptions that broad customer adoption necessarily arrives after a predictable digestion cycle.

The 1-year target is $54.9 for , with +37.80% expected return and a STRONG BUY rating. The 5-year target is $44.5 for , with +11.59% expected return and a PARTIAL SELL rating.

Sherlock Holmes in an AI-generated research persona portrait

Sherlock Holmes AI

Consensus weight Allocation: 7.0/100. Weight Allocation Rationale: Fiscal-calendar scrutiny and the distinction between employee tax withholding and discretionary repurchases strengthen the cash-quality analysis. A recovery supported by collections is a credible alternative path. Domain-only receipts, an unvalidated reconstructed trailing total and ambitious later diversification assumptions reduce confidence in the numerical trajectory without invalidating the underlying concerns.

The 1-year target is $53.4 for , with +34.10% expected return and a STRONG BUY rating. The 5-year target is $68.8 for , with +72.75% expected return and a BUY rating.

Michael Burry in an AI-generated research persona portrait

Michael Burry AI

Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: Customer concentration, working-capital absorption and equipment digestion are economically credible and retain influence. However, domain-only sourcing limits auditability, trailing valuation metrics conflict with documented period duplication, and competitive-margin ceilings are asserted too firmly. Backlog coverage also mixes effective backlog with recognized revenue, weakening the claimed certainty of execution.

The 1-year target is $40.7 for , with +2.06% expected return and a PARTIAL SELL rating. The 5-year target is $42.8 for , with +7.33% expected return and a PARTIAL SELL rating.

Machiavelli in an AI-generated research persona portrait

Niccolo Machiavelli AI

Consensus weight Allocation: 4.0/100. Weight Allocation Rationale: Asian installations and outsourced production establish a real geopolitical transmission channel. The analysis receives limited weight because lacking subsidies does not itself establish competitive weakness, insider sales do not demonstrate management pessimism, and shelf authorization is conflated with ongoing issuance. Supported concentration and dilution insights survive those limitations.

The 1-year target is $51.5 for , with +29.32% expected return and a STRONG BUY rating. The 5-year target is $44.3 for , with +11.20% expected return and a PARTIAL SELL rating.

Ray Dalio in an AI-generated research persona portrait

Ray Dalio AI

Consensus weight Allocation: 4.0/100. Weight Allocation Rationale: The interaction between customer financing, equipment cycles and valuation duration is useful. However, inconsistent concentration definitions, unsupported component-inflation specifics and a terminal cash addition that may overlap earnings valuation weaken the path's foundations. Existing production demand remains credible, but assumed secondary-customer wins and macro timing receive limited reliance.

The 1-year target is $60.7 for , with +52.31% expected return and a STRONG BUY rating. The 5-year target is $61.8 for , with +55.21% expected return and a BUY rating.

Warren Buffett in an AI-generated research persona portrait

Warren Buffett AI

Consensus weight Allocation: 2.0/100. Weight Allocation Rationale: The valuation-versus-cash argument remains relevant, so the compatible path is retained rather than excluded. Its unusually low allocation reflects absent source receipts, an incorrect quarter-end attribution, unreconciled trailing aggregates and mischaracterized repurchases. These defects materially weaken the severe valuation conclusion beyond what better-supported reports establish.

The 1-year target is $46.1 for , with +15.77% expected return and a STRONG BUY rating. The 5-year target is $29.8 for , with -25.25% expected return and a SELL ALL rating.

References & Context

Research Provenance

Analysis generated by iPulse AI Engine v9 using recorded market data, operating under the editorial standards and supervision of Russlan Ramdowar, Editor-in-Chief.

External references below are sources recorded by the researcher agents for this Aehr Test Systems forecast batch.

Primary analysis inputs

  • iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
  • iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
  • Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
  • Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
  • Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.

Sources retained from AI Researcher searches

Asset-specific · Researcher web

40 available sources from this batch (94 recorded). The first 15 are shown below; expand to read the rest.

Some model providers retained only the consulted domain, not an exact article URL. Those domains are shown as evidence without inventing a link.

  1. aehr_10q.htm sec.gov
  2. https://www.sec.gov/Archives/edgar/data/1040470/000165495426009385/aehr_ex991.htm?utm_source=openai sec.gov
  3. www.sec.gov sec.gov
  4. www.sec.gov sec.gov
  5. sec.gov sec.gov
  6. AEHR TEST SYSTEMS - Form 8-K - FY2026 sec.gov
  7. AEHR TEST SYSTEMS - Form 8-K - FY2026 sec.gov
  8. AEHR TEST SYSTEMS - Form 8-K - FY2026 sec.gov
  9. AEHR TEST SYSTEMS - Form 8-K - FY2026 sec.gov
  10. AEHR TEST SYSTEMS - Form 8-K - FY2026 sec.gov
  11. AEHR TEST SYSTEMS - Form S-3ASR - FY2026 sec.gov
  12. aehr_10k.htm sec.gov
  13. aehr_10k.htm sec.gov
  14. aehr_10q.htm sec.gov
  15. fool.com fool.com
Show 25 more sources
  1. stocktitan.net stocktitan.net
  2. investing.com investing.com
  3. perplexity.ai perplexity.ai
  4. aehr.com aehr.com
  5. seekingalpha.com seekingalpha.com
  6. tickeron.com tickeron.com
  7. Aehr Test Systems Expands Silicon Photonics Production Momentum with Follow-On Production Order from Lead Customer - Aehr Test Systems aehr.com
  8. stockstotrade.com stockstotrade.com
  9. tradingview.com tradingview.com
  10. Aehr Receives $22 Million Follow-On Order for AI Processor Wafer-Level Burn-In Systems - Aehr Test Systems aehr.com
  11. finsee.ai finsee.ai
  12. koalagains.com koalagains.com
  13. marketbeat.com marketbeat.com
  14. Microsoft Word - aehr_10k.docx staging.aehr.com
  15. youtube.com youtube.com
  16. Aehr Receives Follow-On Sonoma™ Production Orders for Lead Hyperscale Customer’s Next-Generation AI Processor - Aehr Test Systems aehr.com
  17. PowerPoint Presentation aehr.com
  18. bybit.com bybit.com
  19. finviz.com finviz.com
  20. kalkine.com.au kalkine.com.au
  21. kalkinemedia.com kalkinemedia.com
  22. massive.com massive.com
  23. mlq.ai mlq.ai
  24. publicnow.com publicnow.com
  25. stockanalysis.com stockanalysis.com

54 additional sources are recorded in this batch; their citation details are not available in this publication.

Context retained with this Consensus

The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.

03

Global context snapshot

2026 Year-to-Date Global Market and World-Events Context Through November 14

Download Archived Snapshot

Coverage 2026-01-01 to 2026-11-14 · Knowledge cutoff 2026-11-14

January 1-November 14, 2026: persistent inflation, partial oil supply recovery, US midterms and trade, AI financing, and uneven growth.

Archived context covering 2026-01-01 to 2026-11-14. Its recorded scope includes monetary policy and rates; geopolitics energy and shipping; trade and industrial policy. Selected highlights reflect the analysis cutoff, not current world conditions.

Show moreShow less
File size
96K bytes
Words
14.2K words
Characters
96K characters
Est. tokens (characters ÷ 4)
24K tokens

Fed held at 3.75%-4.00%; Democrats won the next Congress, Nvidia changed leadership and Anthropic filed preliminary IPO terms. Markets through November 13.

Selected highlights from the archived 2026 Year-to-Date Global Market and World-Events Context Through November 14 snapshot
Selected highlights from this archived snapshotDateStatus
Renewed monetary tightening amid persistent inflation2026-01-30ACTIVE POLICY REGIME
Iran/Hormuz conflict and wider energy-security disruption2026-02-28ONGOING
US tariff reset, trade truce and incoming divided government2026-02-20ACTIVE POLICY REGIME

Representative Sources of the Context File

And more sources from the retained context package.

02

Fundamental Context Passed as Input to the Models

Time range: Annual fiscal periods: 2015-05-31–2026-05-31, 12 periods; Quarterly fiscal periods: 2025-05-31–2026-09-30, 12 periods.

Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).

Show moreShow less

Income statement

9 fields

depreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields

Balance sheet

12 fields

cash · commonStockSharesOutstanding · longTermDebt · netDebt · +8 more fields

Cash flow

5 fields

capitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field

End of the paywalled preview

The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Additional with full access

  • Individual AI Advisor reports

    • Investment theses
    • Bull and bear scenarios and alpha signals
    • Drivers, headwinds, risks and opportunities
    • Quarterly forecast rationale
    • Advisor research references and configuration
  • Additional datasets and interactive tools

    • Interactive forecast comparisons
    • Available detailed financial statements
    • Market history and corporate-action adjustments
    • Eligible historical publication workspaces

Explore complete public research examples

These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.

Aehr Test Systems: forecast questions

What is Aehr Test Systems (AEHR)'s 1-year price forecast?

Aehr Test Systems's 1-year target is $47.5 for Nov 2027. The current AI rating is STRONG BUY. The expected return from the recorded close is +19.23%, or +19.23% modeled return including net dividends. Latest available market price: USD 39.8, as of 20 Nov 2026. The target date is fixed at publication.

What is Aehr Test Systems (AEHR)'s 5-year price forecast?

Aehr Test Systems's 5-year target is $55.0 for Nov 2031. The current AI rating is NEUTRAL. The expected return from the recorded close is +38.05%, or +38.05% modeled return including net dividends. Latest available market price: USD 39.8, as of 20 Nov 2026. The target date is fixed at publication.

How can I compare the AI opinions and audit past Aehr Test Systems forecasts?

11 AI analysts contribute to this publication. AI Opinions shows individual advisor forecasts and reasoning. Forecast History lists the available batches with their original publication dates.

How does an AI-generated forecast for Aehr Test Systems differ from Wall Street analyst consensus?

Wall Street consensus aggregates estimates from human analysts. For listed companies, these typically include brokerage price targets, earnings forecasts and ratings. iPulse AI's forecast for Aehr Test Systems is a separate AI consensus generated through its own research workflow. Different inputs, forecast dates, assumptions and weighting can therefore produce different targets.

We believe the era of investment research conducted only by human analysts is drawing to a close. Frontier models increasingly match or exceed expert work on selected professional benchmarks, including evaluations covering financial analysis. Research on multi-model synthesis also shows that combining model responses can improve on a single model's output in the tasks studied.

iPulse AI generates transparent investment research and market forecasts using a swarm of AI configurations, analytical frameworks and frontier models. The workflow applies multiple verification, challenge and synthesis layers, with selective editorial review under Russlan Ramdowar, Editor-in-Chief. Published assumptions, disagreements and past forecasts remain available so readers can inspect the reasoning and audit outcomes.

For a research cycle covering 426 assets with 14 perspectives per asset, our internal workload model estimates approximately 114,000 hours of traditional analyst work. It assumes 16 hours per individual research report, 28 hours per consensus for synthesis and validation, plus shared data preparation. Parallel AI execution allows a deep-analysis cycle across hundreds of assets to complete in up to one day. The human-hours figure is an illustrative workload estimate, rather than measured time savings. Our research methodology explains the automated workflow.

If iPulse AI produces thousands of investment reports - work estimated to require over 100,000 traditional analyst hours - isn't that just "AI slop" at scale?

No. iPulse AI produces AI-generated research at scale, but the purpose is depth of analysis, comparison, and accountability. The number of reports is a consequence of the research process; it is not the goal.

iPulse AI does not produce thin copies of existing websites, articles, or investment reports. We use frontier models as an Analytical Intelligence layer. Our Financial Experts select, validate, curate, and supply the input data, including proprietary inputs, so the models work from a prepared evidence base.

In Researcher mode, models can also search the web to check current information, test assumptions, and investigate evidence that may be missing from the supplied data. This can include lobbying expenditure, management developments, regulatory decisions, or other facts relevant to a particular investment thesis. Thinker mode focuses on deep reasoning over the supplied data and context.

Our process goes much further than asking ChatGPT to evaluate a stock. Our team designs structured investment frameworks inspired by the approaches of influential investors, economists, political thinkers, and technological visionaries. These are AI analytical frameworks, not reports written or endorsed by the people who inspired them.

Each asset is analyzed separately through multiple frameworks and configurations, using specialized inputs and task instructions. Different perspectives examine different questions: valuation, business quality, technological disruption, macroeconomic conditions, political influence, financial risks, and more.

Cloud infrastructure allows these workflows to run at scale. That scale also comes with quality assurance at scale: up to 30% of report-generation attempts fail our QA checks. We rerun failed attempts until a clean report passes those checks. Users are presented only with reports that have passed QA.

This explains the volume. The value comes from what we do with the analysis.

A second layer synthesizes the individual reports into an asset-level consensus. This is where we recommend starting when researching a particular asset: it brings together the central thesis, supporting evidence, risks, and disagreements while preserving access to the underlying opinions.

We then compare assets through our proprietary iPulse AI Consensus Score, whose methodology is publicly explained. This helps users move from understanding one asset to comparing opportunities across the analyzed universe.

A further research and editorial layer examines leading candidates, checks current evidence, and develops focused Editorial Top Picks across broad-market and dedicated asset categories. Human editors review the evidence and approve each published edition. For example, explore our Best Long-Term Investments.

But the process does not end when a report is published. We preserve past forecasts so users with the relevant subscription can inspect what the system actually said and compare it with subsequent market outcomes. As more forecasts reach their target dates, the historical record becomes more useful for evaluating which approaches worked, which failed, and under what conditions.

We publish research on our website, arXiv, and Zenodo, alongside explanatory writing on Medium. We use the evidence to refine our data, frameworks, validation, and workflows, and document important findings in Lessons Learned.

The standard we ask users to judge us by is the reasoning, evidence, and historical record behind the research.

How does the iPulse AI Engine work?

The engine runs AI advisor configurations against a shared set of research inputs. The engine history explains the research workflow and what changed between versions.